MEPDF Stock Financial Analysis - MediPal Holdings Corporation (OTCPK) Stock

Overview

Paltac Corporation is a Japan-based company primarily engaged in the wholesale distribution of consumer goods. It operates in a wide range of sectors, including cosmetics, daily necessities, over-the-counter (OTC) pharmaceuticals, health foods, and general merchandise. The company's distribution network spans across Japan, providing a crucial link between manufacturers and retailers. Paltac Corporation also participates in various projects aimed at enhancing its operational efficiency and customer service. These include the implementation of advanced logistics systems, the development of private brand products, and the promotion of sales strategies based on data analysis. The company's commitment to innovation and customer satisfaction has made it a significant player in Japan's wholesale industry.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for MediPal Holdings Corporation as of June 30, 2025 is 3,707,170.00 MM.
The operating income for MediPal Holdings Corporation as of June 30, 2025 is 56,381.00 MM.
The net income for MediPal Holdings Corporation as of June 30, 2025 is 40,857.00 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	3,707,170.00	56,381.00	40,857.00
2025-03-31	3,671,328.00	55,611.00	40,279.00
2024-12-31	3,650,989.00	55,495.00	49,426.00
2024-09-30	3,604,415.00	53,863.00	46,047.00
2024-06-30	3,581,312.00	48,217.00	39,294.00
2024-03-31	3,558,732.00	47,335.00	41,474.00
2023-12-31	3,507,505.00	48,657.00	37,244.00
2023-09-30	3,453,601.00	44,061.00	38,636.00
2023-06-30	3,408,417.00	47,859.00	41,724.00
2023-03-31	3,360,008.00	48,974.00	38,806.00
2022-12-31	3,351,069.00	46,126.00	30,439.00
2022-09-30	3,333,073.00	46,890.00	28,222.00
2022-06-30	3,304,372.00	45,859.00	28,248.00
2022-03-31	3,290,921.00	45,625.00	29,423.00
2021-12-31	3,279,583.00	46,160.00	36,411.00
2021-09-30	3,265,951.00	44,853.00	30,523.00
2021-06-30	3,241,838.00	41,329.00	26,468.00
2021-03-31	3,211,125.00	38,578.00	23,926.00
2020-12-31	3,208,237.00	39,706.00	26,682.00
2020-09-30	3,186,651.00	43,167.00	33,329.00
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	236.48	236.48
2024-09-30	219.56	219.56
2024-06-30	186.44	186.44
2024-03-31	195.83
2023-12-31	175.87	175.62
2023-09-30	182.63	182.61
2023-06-30	197.81	194.83
2023-03-31	184.82	179.12
2022-12-31	144.97	88.30
2022-09-30	134.41	126.15
2022-06-30	134.54	126.13
2022-03-31	140.13	131.41
2021-12-31	173.42	162.74
2021-09-30	145.37	136.36
2021-06-30	126.06	118.19
2021-03-31	113.95	106.80
2020-12-31	127.07	119.16
2020-09-30	158.74	148.97
2020-06-30	173.84	163.34
2020-03-31	175.80	165.33

Cash Flow: Operations, Investing, Financing

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30
2025-03-31	60,559.00	-3,363.00	-25,947.00
2024-12-31
2024-09-30	72,460.00	-3,537.00	-26,886.00
2024-06-30
2024-03-31	61,843.00	-7,817.00	-25,248.00
2023-12-31
2023-09-30	56,888.00	-44,579.00	-49,596.00
2023-06-30
2023-03-31	16,146.00	-39,494.00	-43,541.00
2022-12-31
2022-09-30	26,954.00	-11,326.00	-16,683.00
2022-06-30
2022-03-31	61,216.00	-24,343.00	-16,471.00
2021-12-31
2021-09-30	45,124.00	-17,598.00	-13,961.00
2021-06-30
2021-03-31	34,448.00	-2,939.00	-16,003.00
2020-12-31
2020-09-30	84,718.00	-8,747.00	-54,880.00
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for MediPal Holdings Corporation as of June 30, 2025 is 0.02.
The roe for MediPal Holdings Corporation as of June 30, 2025 is 0.05.
The roic for MediPal Holdings Corporation as of June 30, 2025 is 0.05.
The croic for MediPal Holdings Corporation as of June 30, 2025 is 0.04.
The ocroic for MediPal Holdings Corporation as of June 30, 2025 is 0.08.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.02	0.05	0.05	0.04	0.08
2025-03-31	0.03	0.07	0.06	0.06	0.09
2024-12-31	0.02	0.06	0.06	0.06	0.10
2024-09-30	0.02	0.05	0.05	0.05	0.08
2024-06-30		0.06
2024-03-31		0.05
2023-12-31			0.05	-0.04
2023-09-30			0.06	-0.09
2023-06-30		0.06
2023-03-31		0.06
2022-12-31
2022-09-30		0.00
2022-06-30		0.00	0.00
2022-03-31		0.00
2021-12-31		0.00
2021-09-30	0.00	0.00
2021-06-30	0.02		0.04	0.02	0.05
2021-03-31	0.01	0.04	0.04	0.02	0.05
2020-12-31	0.02	0.04	0.04	0.03	0.13
2020-09-30	0.02	0.06	0.05	0.03	0.13
2020-06-30	0.02	0.06	0.06	-0.01	0.09
2020-03-31	0.02	0.06	0.06	-0.01	0.08

Gross Margins

The gross margin for MediPal Holdings Corporation as of June 30, 2025 is 0.07.
The net margin for MediPal Holdings Corporation as of June 30, 2025 is 0.01.
The operating margin for MediPal Holdings Corporation as of June 30, 2025 is 0.02.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.07	0.01	0.02
2025-03-31	0.07	0.01	0.02
2024-12-31	0.07	0.01	0.01
2024-09-30	0.07	0.01	0.01
2024-06-30
2024-03-31
2023-12-31
2023-09-30		0.01	0.01
2023-06-30		0.01	0.01
2023-03-31		0.01	0.01
2022-12-31
2022-09-30
2022-06-30		0.00	0.00
2022-03-31
2021-12-31
2021-09-30
2021-06-30	0.07	0.01	0.01
2021-03-31	0.07	0.01	0.01
2020-12-31	0.07	0.01	0.01
2020-09-30	0.07	0.01	0.01
2020-06-30	0.07	0.01	0.02
2020-03-31	0.07	0.01	0.02

DE:59Z	€15.30
JP:7459	¥2,685.00